Key statistics dashboard for Ainos, Inc. (AIMD). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Ainos, Inc. operates as a healthcare technology company, specializing in point-of-care diagnostics and the development of safe, novel treatments for various disease indications. Its current portfolio encompasses a COVID-19 antigen rapid test kit, which integrates with a cloud-based test management platform known as the Ainos App, offering both personal and enterprise applications.
Stock Data
| Price | $1.38 |
| Market Cap | $10M |
| Beta | 2.32 |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | -0.54 |
| Price / Book | 3.02 |
| P/S | 731.04 |
| P/FCF | -2.21 |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | -34987.54% |
| EBIT Margin | -100939.04% |
| EBITDA Margin | -65872.76% |
| Operating Margin | -101210.17% |
| Net Margin | -106283.32% |
Financial Health
| Current Ratio | 0.13 |
| Quick Ratio | 0.12 |
| Cash Ratio | 0.09 |
| Debt / Equity | 4.21 |
| Debt / Assets | 70.61% |
| Interest Coverage | -18.84 |
Per-Share Data
| Revenue per share | 0.00 |
| Book Value per share | 0.45 |
| Cash per share | 0.19 |
| FCF per share | -0.61 |
| Tangible Book Value per share | -1.86 |
| Dividend per share | 0.00 |
Related companies: ADTX · ANL · ATHA · BLRX · DARE · FBLG · GOVX
Explore sector: Healthcare · Biotechnology
More sections of AIMD: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks